NervGen Pharma Corp. (NGENF)
USD 1.7
(-9.09%)
USD 1.7
(-9.09%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.23 Million CAD | -44.56% |
| 2022 | 23.87 Million CAD | 33.41% |
| 2021 | 17.89 Million CAD | 168.1% |
| 2020 | 6.67 Million CAD | -1.33% |
| 2019 | 6.76 Million CAD | 118.43% |
| 2018 | 3.09 Million CAD | 3620.63% |
| 2017 | 83.24 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 31.78 Million CAD | 140.14% |
| 2024 Q2 | 27.88 Million CAD | -12.26% |
| 2023 Q3 | 16.35 Million CAD | -6.06% |
| 2023 Q1 | 19.09 Million CAD | -20.0% |
| 2023 FY | 13.23 Million CAD | -44.56% |
| 2023 Q2 | 17.41 Million CAD | -8.81% |
| 2023 Q4 | 13.23 Million CAD | -19.09% |
| 2022 Q1 | 13.89 Million CAD | -22.36% |
| 2022 FY | 23.87 Million CAD | 33.41% |
| 2022 Q4 | 23.87 Million CAD | -17.34% |
| 2022 Q3 | 28.88 Million CAD | 122.45% |
| 2022 Q2 | 12.98 Million CAD | -6.56% |
| 2021 Q2 | 8.69 Million CAD | 37.82% |
| 2021 Q4 | 17.89 Million CAD | 90.83% |
| 2021 Q3 | 9.37 Million CAD | 7.87% |
| 2021 Q1 | 6.3 Million CAD | -5.5% |
| 2021 FY | 17.89 Million CAD | 168.1% |
| 2020 Q1 | 5.42 Million CAD | -19.79% |
| 2020 Q4 | 6.67 Million CAD | -34.87% |
| 2020 FY | 6.67 Million CAD | -1.33% |
| 2020 Q2 | 6.12 Million CAD | 12.93% |
| 2020 Q3 | 10.24 Million CAD | 67.24% |
| 2019 Q3 | 7.06 Million CAD | -21.08% |
| 2019 FY | 6.76 Million CAD | 118.43% |
| 2019 Q4 | 6.76 Million CAD | -4.17% |
| 2019 Q2 | 8.94 Million CAD | -8.31% |
| 2019 Q1 | 9.75 Million CAD | 215.01% |
| 2018 Q1 | - CAD | -100.0% |
| 2018 Q3 | 3.72 Million CAD | 202.12% |
| 2018 Q4 | 3.09 Million CAD | -16.84% |
| 2018 Q2 | 1.23 Million CAD | 0.0% |
| 2018 FY | 3.09 Million CAD | 3620.63% |
| 2017 Q4 | 83.24 Thousand CAD | 0.0% |
| 2017 FY | 83.24 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 65.928% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -83.33% |
| SQZ Biotechnologies Company | 107.18 Million USD | 87.651% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -25.412% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 89.835% |
| Mesoblast Limited | 667.9 Million USD | 98.018% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -18190.639% |
| Genus plc | 1.02 Billion USD | 98.714% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -874.417% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -2552.302% |
| Marizyme, Inc. | 22.01 Million USD | 39.877% |
| ContraFect Corporation | 20.67 Million USD | 35.993% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -2011.008% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -3290.67% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -3363.322% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -824.282% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -219.246% |
| MultiCell Technologies, Inc. | 126.22 USD | -10486368.864% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -1308.553% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 89.7% |
| EV Biologics, Inc. | 431.71 Thousand USD | -2965.924% |
| Q BioMed Inc. | 3.51 Million USD | -276.503% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 62.375% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -1617.527% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -4965.896% |
| Biomind Labs Inc. | 73.81 Thousand USD | -17830.372% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | 97.14% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 55.902% |
| Skye Bioscience, Inc. | 11.94 Million USD | -10.851% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -299.516% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -381.952% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -575.932% |
| IMV Inc. | 31.33 Million USD | 57.758% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -1825.279% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -408.453% |
| GB Sciences, Inc. | 103.44 Thousand USD | -12695.597% |
| Alpha Cognition Inc. | 2.45 Million USD | -439.768% |
| HST Global, Inc. | 1526.00 USD | -867267.038% |
| CSL Limited | 38.02 Billion USD | 99.965% |
| Halberd Corporation | 10.13 Thousand USD | -130548.712% |
| Enzolytics Inc. | 361.7 Million USD | 96.341% |
| Resverlogix Corp. | 8.11 Million USD | -63.106% |
| Affymax, Inc. | 7.44 Million USD | -77.832% |
| SYBLEU INC | 330.46 Thousand USD | -3905.235% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -604.838% |
| argenx SE | 4.54 Billion USD | 99.709% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 52.634% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 72.253% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -58001.141% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -47.902% |
| AVAX Technologies, Inc. | 7.37 Million USD | -79.419% |
| Zenith Capital Corp. | 7410.00 USD | -178523.765% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.609% |
| Ember Therapeutics, Inc. | 184.00 USD | -7193389.674% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -4013.044% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -4964.21% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 97.034% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -813.558% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -337.542% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 74.885% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1326.355% |
| BioStem Technologies, Inc. | 14.56 Million USD | 9.095% |
| ONE Bio Corp. | 70.08 Million USD | 81.114% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -23082.858% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -572887.922% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1239.723% |
| Agentix Corp. | 261.39 Thousand USD | -4963.667% |
| LadRx Corporation | 2.3 Million USD | -473.514% |
| Cell Source, Inc. | 195.17 Thousand USD | -6681.756% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -2654.308% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -3643.039% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -3643.039% |
| NovAccess Global Inc. | 62.24 Thousand USD | -21163.367% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -1969.24% |
| Itoco Inc. | 1.4 Million USD | -845.381% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -13736.96% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -12386.812% |
| Kadimastem Ltd | 2.3 Million USD | -474.46% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -17235.072% |
| CytoDyn Inc. | 11.13 Million USD | -18.858% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -9157.771% |
| Mobile Lads Corp. | 52.00 USD | -25453786.538% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -73926.963% |
| Qrons Inc. | 420.00 USD | -3151333.571% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -3333.727% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -2297.309% |
| Rebus Holdings, Inc. | 5000.00 USD | -264620.42% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -3132.855% |
| International Stem Cell Corporation | 5.39 Million USD | -145.566% |
| Bioxytran, Inc. | 137.63 Thousand USD | -9516.546% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 11.771% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 20.164% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -16654.457% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -1430.747% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -76.081% |
| Neutra Corp. | 2851.00 USD | -464158.892% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 59.156% |
| PureTech Health plc | 693.97 Million USD | 98.093% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -63.993% |
| IXICO plc | 15.84 Million USD | 16.46% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -59.817% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 87.19% |
| CSL Limited | 38.02 Billion USD | 99.965% |
| Cellectis S.A. | 333.99 Million USD | 96.037% |